Bausch + Lomb and Technolas Perfect Vision GmbH (München, Germany) received FDA clearance to bring the VICTUS Femtosecond Laser Platform to U.S. ophthalmologists. The VICTUS permits cataract and corneal procedures to be performed on the same system, and takes variability out of some steps, like the capsulotomy (incision to access the lens) that would normally be done manually.
The system received European clearance late last year (see flashback below).
From the announcement:
LRCS [Laser Refractive Cataract Surgery] may require less phaco energy and time during lens fragmentation, improve intraocular lens placement, and potentially enhance patient outcomes and experience.
LRCS may require less phaco energy and time during lens fragmentation, improve intraocular lens placement, and potentially enhance patient outcomes and experience.
The VICTUS platform is cleared for creation of a corneal flap in patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea and anterior capsulotomy during cataract surgery, with plans to submit additional indications to the FDA. The product is now available for shipment in the U.S.
Flashback: VICTUS Femtosecond Laser Platform for Cataract, Refractive and Therapeutic Procedures
Press release: B+L and TPV Receive 510(k) FDA Clearance from FDA for VICTUS™ Femtosecond Laser Platform
Product page: VICTUS…